|
Volumn 9, Issue 18, 2020, Pages
|
The landscape of cardiovascular clinical trials in the united states initiated before and during covid-19
|
Author keywords
Biomarker; Clinical trial; COVID 19; Renin angiotensin system; Troponin
|
Indexed keywords
CARDIOVASCULAR DISEASE;
CLINICAL PRACTICE;
CLINICAL TRIAL (TOPIC);
CORONAVIRUS DISEASE 2019;
HEART ELECTROPHYSIOLOGY;
HEART FAILURE;
HUMAN;
INTERVENTIONAL CARDIOVASCULAR PROCEDURE;
LETTER;
MEDICAL RESEARCH;
OUTCOME ASSESSMENT;
PATIENT SELECTION;
PRACTICE GUIDELINE;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
UNITED STATES;
BETACORONAVIRUS;
COMPARATIVE STUDY;
CORONAVIRUS INFECTION;
HOST PATHOGEN INTERACTION;
METHODOLOGY;
PANDEMIC;
PATHOGENICITY;
PROCEDURES;
TIME FACTOR;
VIROLOGY;
VIRUS PNEUMONIA;
BETACORONAVIRUS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
CORONAVIRUS INFECTIONS;
HOST-PATHOGEN INTERACTIONS;
HUMANS;
PANDEMICS;
PNEUMONIA, VIRAL;
RESEARCH DESIGN;
TIME FACTORS;
UNITED STATES;
|
EID: 85090065925
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.120.018274 Document Type: Letter |
Times cited : (13)
|
References (5)
|